Rethinking Youth Gender Medicine with Dr Louise Irvine
Dr Louise Irvine, Co-Chair of the Clinical Advisory Network on Sex and Gender, joins the podcast ahead of CAN-SG's London conference on rethinking youth gender medicine. For European listeners, her account of how UK institutions became captured by gender-identity ideology — and how clinical voices are now reclaiming the debate — offers a clear-eyed roadmap for what reform can look like on the continent.
Dr Louise Irvine is a UK general practitioner, GP trainer and Co-Chair of the Clinical Advisory Network on Sex and Gender, known as CAN-SG. She joins Stella O'Malley, Mia Hughes and Dr Bret Alderman to preview CAN-SG's forthcoming two-day conference in London titled Rethinking Youth Gender Medicine, which brings together clinicians, researchers and policymakers to examine how gender medicine for children and adolescents arrived at its current state — and where it should go next. The conversation covers ground that will resonate well beyond the UK. Irvine walks through the central questions of aetiology: why young people are presenting to gender clinics in such unprecedented numbers, and what lies beneath those referrals. She addresses the quality — and striking absence — of evidence underpinning recent practice, the ethical dimensions of treating minors with experimental interventions, and how clinical culture shifted inside institutions that were once expected to apply cautious, rigorous standards. The WellBN clinic, a private provider that operated in the UK and recently came under investigation, receives specific attention as a case study in how providers can function with insufficient oversight. One of the episode's sharpest threads is institutional capture: how bodies like the NHS, which commands enormous trust across Europe as a model health system, came to adopt protocols that lacked a firm evidence base. For listeners in Germany, France and the Netherlands — countries where national health systems carry similar cultural authority — this is not an abstract lesson. When the Dutch protocol that shaped a generation of clinical practice internationally is now being reappraised in the very country that produced it, and when Sweden and Finland have already tightened their guidelines on the basis of systematic evidence reviews, the question of how institutions correct course becomes urgent everywhere. Irvine and the hosts discuss psychotherapy as a meaningful, underused response to gender distress in young people — a position that aligns with the emerging clinical direction visible in Nordic policy reforms. The conversation also examines the puberty blocker trial that the NHS is now conducting, the first properly designed study of its kind, and what rigorous research in this field should actually look like. The concept of evidence-gathering so thin it resembles belief rather than science — shorthand that surfaces in the episode — captures a methodological failure that affected clinicians and regulators in multiple countries simultaneously. For European clinicians and healthcare administrators watching these developments, the CAN-SG conference represents something significant: organised, credentialled clinical voices, not only advocates or parents, demanding an evidence-led rethink. Countries whose health ministries have yet to commission their own systematic reviews — France and Germany among them — have before them a growing body of international precedent. EU institutions, which have shown limited appetite for engaging with the clinical controversy directly, may find the space for inaction shrinking as the reformers' arguments accumulate weight and professional legitimacy across the continent.
